m ore than a century ago, in a report on breast cancer patients, Sir James Paget published pathologic findings involving the areolar tissue of the nipple that was subsequently named after him. since this initial discovery, Paget's disease has been reported in several extramammary sites, including the perineum, vulva, scrotum, groin, axilla, and thigh. 1 Paget's cells represent an intraepithelial adenocarcinoma. their origin has been a subject of debate in the past; however, the distribution of lesions in regions with increased density of apocrine glands suggests that these glands may be the site of origin. 2, 3 Paget's is easily distinguished from Bowen disease if signet ring cells with vacuolated, pale cytoplasm are present; these are usually positive, with a periodic acid-schiff mucin stain ( fig. 1 ). 2, 4 the association between Paget's disease and other carcinomas arising in remote regions of the gastrointestinal tract, genitourinary tract, and remote areas of skin has been noted in previous publications. 5, 6 the relatively rare nature of this disease, however, has made it difficult to develop treatment recommendations. the aim of this study was to review our institution's 60-year experience with this rare disease.
PATIENTS AND METHODS
the pathology department and colorectal surgery service databases at memorial sloan-Kettering Cancer Center were queried for all of the cases of perianal Paget's disease seen between 1950 and 2011. the data were collected and stored in compliance with the health insurance Portability and accountability act regulations, and a waiver of authorization was obtained from the memorial sloan-Kettering Cancer Center Institutional Review Board to allow analysis of patient information. Cases reported in a previous publication from our institution were included in this study, because differences in management and outcome between invasive and noninvasive disease had not been specifically noted. 6 Charts were reviewed, and patients with histologic confirmation of Paget's disease originating in the perianal area were included. All of the cases of Bowen disease were excluded, as it is a disease originating in the perivulvar area.
all of the patients were treated with surgical resection. some required additional surgery to ensure complete tumor clearance. factors included in the study were as follows: 1) age at diagnosis; 2) sex; 3) operative treatment; 4) use of adjuvant treatment; 5) margins of resection; 6) histopathology, including the presence of invasive disease; 7) recurrence; and 8) death. invasive Paget's disease was documented when histopathology identified tumor cells in the stroma underlying the squamous mucosa or skin. locoregional recurrence was defined as biopsy-proven tumor recurrence in inguinal lymph nodes. Primary sources included all of the available medical charts, as well as the tumor registry and social security Death index.
Results were reported as median and corresponding interquartile range or 95% Ci, as appropriate. Recurrence-free survival, disease-specific survival (Dss), and overall survival were calculated using the Kaplan-meier product-limit method, and the difference was measured by the log-rank test. Continuous variables were compared with the χ 2 test. a p value of <0.05 was considered statistically significant. Statistical analyses were performed with IBM SPSS software version 20 (IBM SPSS Inc, Chicago, IL).
RESULTS
Patient and Tumor Characteristics sixty-five patients met the inclusion criteria, of whom 35 (54%) were women (table 1). the median age at the time of diagnosis was 66 years (range, 60-72 years). invasive Paget's disease was noted in 41 patients and noninvasive disease in 24. fifty-six percent of patients with invasive disease were men. ninety-five percent of patients with invasive disease and 87% of patients with noninvasive disease were symptomatic. the most common symptoms included pruritus and perianal bleeding. the duration of symptoms before the diagnosis of Paget's disease was significantly longer in patients with invasive disease (12.0 months; range, 4.0-18.0 months) compared to those with noninvasive lesions (3.5 months; range, 1.0-10.0 months; p = 0.02). synchronous malignancies, unrelated to the primary Paget's, were noted in 5 patients with invasive and 3 with noninvasive disease. these included bladder cancer (n = 1), thyroid cancer (n = 1), endometrial cancer (n = 1), lymphoma (n = 1), breast cancer (n = 2), and basal cell carcinoma (n = 2).
Management
Patients with a diagnosis of noninvasive Paget's disease were treated with wide local excision (Wle). Patients diagnosed with invasive disease, either at the time of presentation or after initial excision, were treated with Wle or abdominoperineal resection (aPR), 32 (78%) with Wle and 9 (22%) with aPR (table 1) Dss was significantly shorter in patients with invasive Paget's disease (10.9 years; 95% Ci, 4.5-12.0 years) compared with those with noninvasive disease (median not reached; p = 0.004; fig. 2 ). overall survival was signifi- fig. 2 ). in patients with invasive disease, surgical resection (Wle vs aPR) did not affect recurrence or Dss (table 1  and fig. 3 ). the cohort of patients receiving adjuvant treatment was small; therefore, analysis of its effect was limited.
DISCUSSION
Perianal Paget's is a rare disease. most reported series are small and biased toward invasive disease. in this series we report on 65 patients with perianal Paget's disease who were treated at memorial sloan-Kettering Cancer Center over a 60-year period. not surprisingly, the majority had nonspecific perianal symptoms, including pain and pruritus, which can mimic more common, benign anorectal problems, such as hemorrhoids, pruritus ani, and fissures. this often leads to a delay in diagnosis.
Delay may also result from difficulty in securing a correct pathologic interpretation. Differentiation of Pagetoid cells from those associated with Bowen disease or anal melanoma can be difficult for the nonspecialized pathologist. 7 furthermore, invasive and noninvasive Paget's diseases commonly coexist. this makes the identification of invasive disease more challenging. Repeat diagnostic procedures are often required.
invasive Paget's disease may be primary or secondary. the cell of origin for primary Paget's disease has been an issue of debate in the literature. Presumed cells of origin have included pluripotent epidermal stem cells, adnexal stem cells, apocrine glands, and intraepidermal toker cells. secondary Paget's disease often results from a downward spread of rectal adenocarcinoma 2 ; thus, it is not surprising that a diagnosis of Paget's disease is associated with colorectal cancer. 8 Distinguishing primary from secondary anal Paget's disease is not always clear-cut.
in our series, the high proportion of patients who were ultimately diagnosed with invasive disease (41 of 65 [63%]) is a result of the institution's tertiary referral pattern. invasive disease is usually identified after an attempted local excision for what is thought to be noninvasive disease. although aPR was required only in patients with invasive disease, some with noninvasive disease required significant local excision and perineal reconstruction.
Recurrence remains a common problem, even after apparent complete resection. in our series, half of the patients with invasive perianal Paget's and one quarter of those with noninvasive disease experienced recurrence. this is undoubtedly related to the skip nature of the disease, meaning its discontinuous spread of Pagetoid cells in the epidermis beyond the clinically apparent margin. For this reason, Beck and fazio 9,10 recommend routine perianal biopsies 1 cm from the edge of the visible lesion, in all 4 quadrants, before resection. in this series, we liberally used mapping with 4-mm dermatologic punch biopsies taken at 1-cm intervals beyond the visible margin of the lesion to define the extent of local excision. however, in light of the high local recurrence rate of Paget's disease noted in this and other studies, 11 the value of such extensive mapping procedures is uncertain.
We found that half of the recurrences in this study were delayed and diagnosed 5 years after the primary resection. although the goal of treating perianal Paget's disease is to maximize local control, surgical deformity and morbidity should be minimized. sphincter preservation to optimize quality of life is paramount in patients with noninvasive disease. 11 Patients with invasive disease should be considered for more aggressive surgery, including aPR if necessary. the role of neoadjuvant radiation to assist in complete resection or to avoid aPR may deserve investigation, but was not used in our cohort. however, it is important to individualize treatment on the basis of the patient's desires, functional status, and comorbidities, as well as the extent of disease. in this as in previous studies, 6 a proportion of patients with invasive Paget's succumb to disease. of 41 patients with invasive Paget's disease in the current analysis, 10 (16%) died of disease and 8 (20%) of other causes. the current study, like all retrospective analyses, is limited by selection bias. this most likely explains why we noted no difference in recurrence-free survival between patients undergoing Wle and aPR; patients with extensive, and possibly aggressive, disease were more likely to require aPR. similarly, we are not able to comment on the use of adjuvant therapy. Patients undergoing adjuvant treatment had worse survival rates compared with those who did not undergo adjuvant treatment; however, it may be the case that patients with extensive disease were more likely to be offered adjuvant therapy (radiation or chemoradiation). similar observations have been reported in the existing literature. 12 
